Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives

T. Blum (Berlin, Germany)

Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Session: PG1 Lung cancer: the key multidisciplinary approach
Session type: Postgraduate Course
Number: 82
Disease area: -

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Blum (Berlin, Germany). Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives. International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer
Year: 2006

The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum
Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy
Year: 2017


Lung cancer: clinical presentation and specialist referral time
Source: Eur Respir J 2004; 24: 898-904
Year: 2004



The role of bronchoscopy in the diagnosis of lung cancer: an audit to assess standards
Source: Eur Respir J 2001; 18: Suppl. 33, 62s
Year: 2001

Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Source: Eur Respir J 2014; 44: 1011-1022
Year: 2014



Repeat diagnostic thoracocentesis in lung cancer staging – fiddling whilst Rome burns?
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Diagnostic yield, clinical impact and cost aspect of EBUS-TBNA in mediastinal staging in lung cancer
Source: Annual Congress 2012 - Progress in endoscopy for lung cancer
Year: 2012


Mediastinal staging in lung cancer: A rational approach
Source: Annual Congress 2010 - Staging of lung cancer
Year: 2010


Feasibility, yield and impact of ambulatory EBUS-TBNA for the diagnosis and staging of lung cancer
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007


Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer
Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies
Year: 2013


PET-CT a useful staging tool for patients with non small lung cancer when applied based on surgeons‘ discretion as well as guidelines
Source: Annual Congress 2010 - State of the art imaging
Year: 2010

Is time from "referral to diagnosis" in lung cancer pathway affected by diagnostic test delays?
Source: International Congress 2015 – Quality management in lung cancer
Year: 2015

What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities
Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules
Year: 2018


The use of surgical services in the management of suspected lung cancers
Source: Annual Congress 2012 - Epidemiology and care research of lung cancer
Year: 2012


Modern staging in lung cancer: from the current multidisciplinary process to novel approaches
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019


New insights into lung cancer: what radiologists can contribute to diagnosis and staging
Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Year: 2019